NEW DELHI: The Health Ministry on Saturday recommended the use of antiviral drug Remdesivir in a moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating coronavirus-infected patients in a moderate stage of the illness.
In its revised ‘Clinical Management Protocols for COVID-19,’ the ministry dropped the use of azithromycin in combination with hydroxychloroquine (HCQ) in severe cases and requiring ICU management.
► TV9 Kannada Website:
► Subscribe to Tv9 Kannada:
► Like us on Facebook:
► Follow us on Twitter:
► Download TV9 Kannada Android App:
► Download TV9 Kannada IOS App:
► Follow us on Instagram:
► Join us on Telegram:
► Follow us on Pinterest:
#TV9Kannada #Healministry #Covid19 #Remedsiver
